USCACA committee members with Dr. Zhu Chen at 2013 SZENT-GYÖRGYI PRIZE CEREMONY OF NFCR

USCACA sponsored a table at the 2013 Szent-Gyorgyi Prize Ceremony of the National Foundation for Cancer Research (NFCR). This year, the prestigious award went to Alex Matter, M.D., CEO of the Experimental Therapeutic Centre of Agency for Science, Technology and Research (A*STAR) in Singapore, Member of the Swiss Academy of Medical Sciences. The award recognizes his tremendous contribution in the development of Gleevec. Dr. Zhu Chen, the former Minister of Health of China, the co-winner of the same prize in 2012 (with Zheng-Yi Wang) introduced Alex Matter as the “Father of Targeted Therapy” and presented Dr. Matter with the prize. The prize ceremony was attended with many leaders in cancer research and therapies in both US and China. Ten members of the USCACA executive committee attended the ceremony and had a pleasant greeting with Dr. Zhu Chen, Dr. Alex Matter, and other attendees.

Picture of USCACA executive committee members with Dr. Zhu Chen.